6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Cancer of Gastrointestinal Tract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mosienko, BI | 1 |
1 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
[Efficacy of the myocardium cytoprotection in patients with ischemic heart disease during extended operations on abdominal organs].
Topics: Cardiac Output; Cardiotonic Agents; Cytoprotection; Gastrointestinal Neoplasms; Humans; Middle Aged; Myocardial Ischemia; Myocardium; Picolines; Premedication; Time Factors | 2013 |